Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 15/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TDP2 | O95551 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20989880 | 1.00 | PDK2 (0.37) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL29376474 | 0.92 | PDK2 (0.33) | PDK2ALDH1A1TDP2 | |
| SCHEMBL26104565 | 0.92 | PDK2 (0.33) | PDK2ALDH1A1TDP2 | |
| SCHEMBL30396812 | 0.90 | HDAC2 (0.32) | PDK2ALDH1A1 | |
| SCHEMBL30132162 | 0.89 | PDK2 (0.45) | PDK2MAPTL3MBTL1TDP2APEX1 | |
| SCHEMBL3289778 | 0.89 | PDK2 (0.45) | PDK2MAPTL3MBTL1TDP2APEX1 | |
| SCHEMBL16294578 | 0.89 | PDK2 (0.45) | PDK2MAPTL3MBTL1TDP2APEX1 | |
| SCHEMBL13979699 | 0.89 | MMP2 (0.39) | PDK2LTB4R2 | |
| SCHEMBL26105343 | 0.88 | RAB9A (0.41) | KDM4EALDH1A1MAPT | |
| SCHEMBL11942814 | 0.88 | MMP2 (0.40) | PDK2LTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2929325-B1 | METHOD FOR THE DETECTION OF ANALYTES VIA LUMINESCENCE QUENCHING | UNIV QUEENSLAND (AU) | 2020-06-24 | — | — | EP | disclosed |
| US-20190137395-A1 | METHOD FOR THE DETECTION OF ANALYTES VIA LUMINESCENCE QUENCHING | UNIV QUEENSLAND (AU) | 2019-05-09 | — | — | US | disclosed |
| US-20180100801-A1 | METHOD FOR THE DETECTION OF ANALYTES VIA LUMINESCENCE QUENCHING | UNIV QUEENSLAND (AU) | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190137395-A1 | METHOD FOR THE DETECTION OF ANALYTES VIA LUMINESCENCE QUENCHING | TYR, MAOA, AS3MT | PDK2 4169/4885KDM4E 2197/4885ALDH1A1 1114/4885 |
| US-20180100801-A1 | METHOD FOR THE DETECTION OF ANALYTES VIA LUMINESCENCE QUENCHING | TYR, MAOA, AS3MT | PDK2 4169/4885KDM4E 2197/4885ALDH1A1 1114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.